 |
市场调查报告书
商品编码
1741542
全球微生物 API 市场：按宿主、类型、最终用户和地区划分Global Microbial API Market, By Host, By Type, By End User, By Region |
||||||
预计 2025 年全球微生物 API 市场规模为 696.9 亿美元，到 2032 年将达到 1,097.3 亿美元，2025 年至 2032 年的复合年增长率为 6.7%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 696.9亿美元 |
| 效能数据 | 从2020年到2024年 | 预测期 | 2025年至2032年 |
| 预测期：2025-2032年复合年增长率： | 6.70% | 2032年价值预测 | 1097.3亿美元 |
微生物API是指利用各种微生物（例如细菌、真菌和酵母）透过微生物发酵产生的治疗物质或活性药物成分。微生物API主要分为两类：小分子API和大分子API。小分子原料药是通常透过化学合成生产的小型治疗物质。大分子原料药 ，通常称为生技药品，是透过重组DNA技术或受控微生物发酵生产的复杂治疗物质，例如单株抗体、疫苗、血液因子等。
大分子微生物API相较于小分子原料药具有一定优势。其高标靶特异性和低毒性使其对癌症、糖尿病等慢性疾病有更佳的治疗效果。此外，利用活微生物生产大分子微生物製剂的工艺，使其能够灵活地生产各种个人化医疗产品。
市场动态：
全球微生物API市场受学名药药和生物相似药需求成长的驱动，这源自于成本效益的提升。此外，微生物发酵在反应特异性、生产率和产量方面均优于化学合成，促使製药商加强对微生物API生产的投资。然而，建立、开发和扩大大分子微生物API生产流程的资本要求高，该製程复杂且资本密集，严格的监管流程预计将成为限制市场成长的一些因素。
创新发酵技术的开发有助于降低生产成本，为微生物API製造商提供了丰厚的机会。此外，作为生物製品，如果生产过程缺乏严格的品管，它们容易产生杂质和批次间不一致。这导致大分子量微生物API面临更高的监管门槛和更高的产品成本。
从地区来看，北美由于医疗成本高且医疗服务便捷而占据市场主导地位。然而，亚太地区是成长最快的市场，主要由中国和印度等国家推动。这一增长归因于经济成长、可支配收入的增加、医疗基础设施的扩张以及对生技药品需求的不断增长。
本研究的主要特点
- 本报告对全球微生物 API 市场进行了详细分析，并提供了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）（假设 2024 年为基准年）。
- 它揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 全球微生物 API 市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球微生物 API 市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员可以透过用于分析全球微生物 API 市场的各种策略矩阵来促进决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章 关键产业洞察
- 市场动态
- 驱动程式
- 限制因素
- 机会
- 影响分析
- PEST分析
- 波特分析
- 技术进步
- 合併、收购和合作场景
- 最近的产品核可/发布
- 公司市场占有率分析
4. 2020 年至 2032 年全球微生物 API 市场（依宿主划分）
- 哺乳动物
- 细菌
- 真菌
5. 2020 年至 2032 年全球微生物 API 市场（按类型）
- 抗体
- 胜肽
- 蛋白质
- 小分子
- 疫苗
6. 2020 年至 2032 年全球微生物 API 市场（按站点划分）
- 内部
- 外包
7. 2020 年至 2032 年全球微生物 API 市场（依最终用户划分）
- 製药公司
- 生物製药公司
- 其他的
8. 全球微生物 API 市场（按分子划分），2020-2032 年
- 原厂产品
- 非专利的
9. 2020 年至 2032 年全球微生物 API 市场（按地区）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第十章 公司概况-微生物 API 市场
- KOLON LIFE SCIENCE
- 公司简介
- 产品/服务组合
- 财务表现
- 最新动态/更新
- 策略概述
- Shandong Lukang Pharmaceutical Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
- Lonza
- Merck &Co., Inc.
- Topfond Pharmaceutical Co., Ltd.
- DSM
- CSPC Pharmaceutical Group Limited
第 11 章参考文献与调查方法
- 参考
- 调查方法
Global Microbial API Market is estimated to be valued at USD 69.69 Bn in 2025 and is expected to reach USD 109.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 69.69 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.70% | 2032 Value Projection: | USD 109.73 Bn |
Microbial APIs refer to therapeutic substances or active pharmaceutical ingredients produced through microbial fermentation using various microorganisms such as bacteria, fungi, or yeast. There are mainly two types of microbial APIs: small molecule APIs and large molecule APIs. Small molecule APIs are low-molecular-weight therapeutic substances that are usually produced through chemical synthesis. Large molecule APIs, commonly known as biologics, are complex therapeutic substances like monoclonal antibodies, vaccines, blood factors, etc. that are produced by recombinant DNA technology or controlled microbial fermentation.
Large molecule microbial APIs have certain advantages over small molecule APIs. Due to their high target specificity and lower toxicity, they provide better treatment outcomes for chronic diseases like cancer, diabetes, etc. The manufacturing process of large molecule microbial APIs using living microbes also allows for flexible production of a wide range of product variants catering to personalized medicine.
Market Dynamics:
The global microbial API market is driven by the rising demand for generic and biosimilar drugs owing to cost efficiency. Moreover, microbial fermentation offers advantages over chemical synthesis in terms of reaction specificity, productivity, and yields, which is encouraging pharmaceutical manufacturers to increase investment in microbial API production. However, the high capital requirement for setting up microbial fermentation facilities, developing, and scaling up the manufacturing process of large molecule microbial APIs is complex and capital-intensive and stringent regulatory processes are some of the factors expected to restrain market growth.
The development of innovative fermentation technologies to decrease production costs presents lucrative opportunities for microbial API manufacturers. Additionally, being biological products, they are more prone to impurities and batch-to-batch inconsistencies if not manufactured under stringent quality controls. This raises regulatory hurdles and the cost of goods for large molecule microbial APIs.
Among regions, North America dominates the market due to high healthcare expenditures and better access to care. However, Asia Pacific is poised to be the fastest-growing market arena, led by countries like China and India. This growth can be attributed to growing economies, rising disposable incomes, expanding medical infrastructure, and increasing demand for biologics.
Key features of the study:
- This report provides in-depth analysis of the global microbial API market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global microbial API market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck & Co., Inc., Topfond Pharmaceutical Co., Ltd., DSM, CSPC Pharmaceutical Group Limited., KOLON LIFE SCIENCE, Teva Pharmaceutical Industries Ltd., Lonza, Akums Lifesciences Ltd., AbbVie Inc., Xellia Pharmaceuticals, BASF, Dr. Reddy's Laboratories and Lupin
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global microbial API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microbial API market
Detailed Segmentation:
Global Microbial API Market
- By Host
- Mammalian
- Bacterial
- Fungal
- By Type
- Antibody
- Peptide
- Protein
- Small Molecule
- Vaccine
- By Site
- In-house
- Outsourced
- By End User
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others
- By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Merck & Co., Inc.
- Topfond Pharmaceutical Co., Ltd.
- DSM
- CSPC Pharmaceutical Group Limited.
- KOLON LIFE SCIENCE
- Teva Pharmaceutical Industries Ltd.
- Lonza
- Akums Lifesciences Ltd.
- AbbVie Inc.
- Xellia Pharmaceuticals
- BASF
- Reddy's Laboratories
- Lupin
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Top 3 Market Findings
- Top 3 Market Opportunity
3. Key Industry Insights
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Pest Analysis
- Porters Analysis
- Technological Advancement
- Merger, Acquisition and Collaboration Scenario
- Recent Product Approvals/Launches
- Company Market Share Analysis
4. Global Microbial API Market, By Host, 2020 - 2032 ( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
- Mammalian, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Bacterial, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Fungal, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
5. Global Microbial API Market, By Type, 2020 - 2032 ( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
- Antibody, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Peptide, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Protein, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Small Molecule, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Vaccine, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
6. Global Microbial API Market, By Site, 2020 - 2032 ( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
- In-house, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Outsourced, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
7. Global Microbial API Market, By End user, 2020-2032, (US$ Bn)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
- Pharmaceutical Companies, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Biopharmaceutical Companies, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Others, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
8. Global Microbial API Market, By Molecule, 2020 - 2032 ( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
- Innovative, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Generic, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
9. Global Microbial API Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2020 - 2032, ( US$ Billion)
- Segment Trends
- By Region
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- North America
- Introduction
- Market Size and Forecast, By Host, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Site, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End-use, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Molecule, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
- U.S.
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Canada
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Europe
- Introduction
- Market Size and Forecast, By Host, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Site, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End-use, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Molecule, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
- U.K
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Germany
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- France
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Italy
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Spain
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Russia
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Rest of Europe
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Asia Pacific
- Introduction
- Market Size and Forecast, By Host, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Site, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End-use, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Molecule, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
- China
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- India
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Japan
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Australia
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- South Korea
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- ASEAN
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Latin America
- Introduction
- Market Size and Forecast, By Host, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Site, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End-use, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Molecule, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
- Brazil
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Mexico
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Argentina
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Rest of Latin America
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Middle East
- Introduction
- Market Size and Forecast, By Host, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Site, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End-use, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Molecule, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
- GCC
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Israel
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Rest of Middle East
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Africa
- Introduction
- Market Size and Forecast, By Host, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Site, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End-use, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
- North Africa
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Central Africa
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- South Africa
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
10. Company Profiles - Microbial API Market
- KOLON LIFE SCIENCE
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Shandong Lukang Pharmaceutical Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
- Lonza
- Merck & Co., Inc.
- Topfond Pharmaceutical Co., Ltd.
- DSM
- CSPC Pharmaceutical Group Limited
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
下一代生物治疗市场－全球产业规模、份额、趋势、机会及预测，按治疗领域、技术、地区及竞争情况细分，2020-2030 年青霉素 G 钠市场 - 全球产业规模、份额、趋势、机会和预测，按销售管道、最终用途、地区和竞争细分，2020-2030 年卡马西平市场－全球产业规模、份额、趋势、机会和预测，按销售管道、最终用途、地区和竞争细分，2020-2030 年
活性药物成分市场规模、份额及成长分析（按分子、类型、製造商、化学合成、治疗用途和地区）－2025-2032 年产业预测
聚多卡醇注射液市场按产品类型、浓度等级、包装形式、应用、年龄层、最终用户划分 - 2025 年至 2030 年全球预测全球维生素 API 市场按类型、类别、纯度、製造类型、标准、等级、最终用户和地区划分医疗保健 API 市场规模、份额和成长分析（按服务、部署、最终用户和地区）- 产业预测 2025-2032大宗药品市场 - 全球产业规模、份额、趋势、机会和预测，按类型、按最终用户、按地区、竞争情况细分，2020-2030 年预测
原料药(API) 市场分析及预测至 2033 年：依类型、产品、服务、技术、应用、形式、流程、最终使用者、阶段Articaine阿替卡因市场规模、份额和成长分析（按应用程式、最终用户和地区）- 产业预测，2025-2032 年